CTCAE versión 5.0. Evaluación de la gravedad de los eventos adversos dermatológicos de las terapias antineoplásicas-Reference-Cited by-同舟云学术

CTCAE versión 5.0. Evaluación de la gravedad de los eventos adversos dermatológicos de las terapias antineoplásicas

Published:2021-01 Issue:1 Volume:112 Page:90-92
ISSN:0001-7310
Container-title:Actas Dermo-Sifiliográficas
language:es
Short-container-title:Actas Dermo-Sifiliográficas

Author:

Freites-Martinez A.,Santana N.,Arias-Santiago S.,Viera A.

Publisher

Elsevier BV

Subject

Dermatology,Histology,Pathology and Forensic Medicine

Reference9 articles.

1. Cancer incidence and mortality worldwide: Sources, methods and major patterns in globocan 2012;Ferlay;Int J Cancer.,2015

2. The risk of rash associated with ipilimumab in patients with cancer: A systematic review of the literature and meta-analysis;Minkis;J Am Acad Dermatol.,2013

3. Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: A randomised phase iii study with crossover on progression by the Scandinavian breast group;Sjostrom;Eur J Cancer.,1999

4. Common Terminology Criteria for Adverse Events (CTCAE) Version 5. Published: November 27. US Department of Health and Human Services, National Institutes of Health, National Cancer Institute.

5. Clinical characterization of immunotherapy-related pruritus among patients seen in 2 oncodermatology clinics;Phillips;JAMA Derm.,2019

Cited by 391 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of concurrent chemoradiotherapy with paclitaxel-based or S-1 regimens in treating elderly patients with esophageal squamous cell carcinoma: A multi-center propensity-score matched study;Translational Oncology;2024-12

2. Impact of preexisting interstitial lung disease on outcomes of lung cancer surgery: A monocentric retrospective study;Respiratory Medicine and Research;2024-11

3. Comparison of immunochemotherapy followed by surgery or chemoradiotherapy in locally advanced esophageal squamous cell cancer;International Immunopharmacology;2024-11

4. Exploring the impact of BRCA1 and BRCA2 mutation type and location on Olaparib maintenance therapy in platinum-sensitive relapsed ovarian Cancer patients: A single center report;Gynecologic Oncology;2024-11

5. A two-stage ensemble learning based prediction and grading model for PD-1/PD-L1 inhibitor-related cardiac adverse events: A multicenter retrospective study;Computer Methods and Programs in Biomedicine;2024-10